Atea Pharmaceuticals, Inc. - Common Stock (AVIR)
CUSIP: 04683R106
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 78,888,889
- Total 13F shares
- 56,687,549
- Share change
- +2,274,423
- Total reported value
- $187,637,646
- Put/Call ratio
- 443%
- Price per share
- $3.31
- Number of holders
- 101
- Value change
- +$7,123,002
- Number of buys
- 46
- Number of sells
- 57
Quarterly Holders Quick Answers
What is CUSIP 04683R106?
CUSIP 04683R106 identifies AVIR - Atea Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04683R106:
Top shareholders of AVIR - Atea Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
12%
|
9,243,306
|
$37,342,956 | — | 31 Mar 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
7.8%
|
6,145,861
|
$24,829,278 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
7.3%
|
5,779,029
|
$23,347,277 | — | 31 Mar 2024 | |
| BML Capital Management, LLC |
13F
|
Company |
7%
|
5,536,710
|
$22,368,308 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6%
|
4,722,522
|
$19,078,989 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
5.2%
|
4,076,741
|
$16,470,034 | — | 31 Mar 2024 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
3.2%
|
2,485,638
|
$10,041,978 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
1,882,480
|
$7,606,012 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,678,383
|
$6,780,667 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.4%
|
1,123,400
|
$4,539,000 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.2%
|
962,458
|
$3,886,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.87%
|
687,269
|
$2,776,567 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.85%
|
672,984
|
$2,718,855 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.78%
|
612,319
|
$2,473,769 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.73%
|
577,400
|
$2,332,696 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.72%
|
571,359
|
$2,308,290 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.51%
|
404,639
|
$1,634,742 | — | 31 Mar 2024 | |
| Newtyn Management, LLC |
13F
|
Company |
0.51%
|
400,000
|
$1,616,000 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.49%
|
382,932
|
$1,547,044 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.47%
|
372,250
|
$1,503,890 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.44%
|
350,004
|
$1,414,016 | — | 31 Mar 2024 | |
| BANQUE PICTET & CIE SA |
13F
|
Company |
0.44%
|
345,077
|
$1,394,111 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.37%
|
291,091
|
$1,176,008 | — | 31 Mar 2024 | |
| CM Management, LLC |
13F
|
Company |
0.34%
|
270,000
|
$1,090,800 | — | 31 Mar 2024 | |
| Acuitas Investments, LLC |
13F
|
Company |
0.33%
|
257,910
|
$1,041,956 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.3%
|
239,557
|
$967,811 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.27%
|
212,763
|
$859,563 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.26%
|
207,759
|
$839,346 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.26%
|
207,069
|
$836,559 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.25%
|
196,264
|
$792,906 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.25%
|
196,000
|
$791,840 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.24%
|
185,411
|
$749,061 | — | 31 Mar 2024 | |
| Auour Investments LLC |
13F
|
Company |
0.22%
|
177,000
|
$715,080 | — | 31 Mar 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.22%
|
171,368
|
$692,327 | — | 31 Mar 2024 | |
| RBF Capital, LLC |
13F
|
Company |
0.19%
|
148,451
|
$599,742 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.18%
|
145,532
|
$587,948 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.18%
|
141,902
|
$573,271 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.16%
|
128,900
|
$520,756 | — | 31 Mar 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.15%
|
116,655
|
$471,000 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.15%
|
116,420
|
$470,337 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.14%
|
109,258
|
$441,402 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.13%
|
105,818
|
$427,505 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
104,070
|
$420,442 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.13%
|
103,256
|
$417,153 | — | 31 Mar 2024 | |
| STRS OHIO |
13F
|
Company |
0.12%
|
94,700
|
$382,000 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.12%
|
94,125
|
$380,265 | — | 31 Mar 2024 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.1%
|
80,830
|
$326,553 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.09%
|
70,000
|
$283,000 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.09%
|
67,137
|
$272,000 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.09%
|
67,111
|
$271,128 | — | 31 Mar 2024 |
Institutional Holders of Atea Pharmaceuticals, Inc. - Common Stock (AVIR) as of Q2 2024
As of 30 Jun 2024,
Atea Pharmaceuticals, Inc. - Common Stock (AVIR) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,687,549 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, BML Capital Management, LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, Bain Capital Life Sciences Investors, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and Almitas Capital LLC.
This page lists
102
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
112
Q2 2024 holders
101
Holder diff
-11
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.